Pharmacogenomics and the Impact on Target Populati..

Yeni bir makale oluşturdu

1 hafta

Pharmacogenomics and the Impact on Target Population for PLK1 Inhibitors | #plk1

Pharmacogenomics and the Impact on Target Population for PLK1 Inhibitors

Pharmacogenomics and the Impact on Target Population for PLK1 Inhibitors

Pharmacogenomics is playing an essential role in identifying the right target populations for PLK1 inhibitors. As more genetic insights are integrated into cancer treatment, PLK1 inhibitors are poised to become a key part of personalized oncology therapies.

Beğen

Yorum yap

Paylaş